Clinical Trial Update: A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial update for LY900014 with insulin lispro using an external insulin infusion in adults with type 1 diabetes; trial completed with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• LY900014
• insulin lispro (insulin lispro)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2019-10-08